Companies: 10,795·Total market cap: $144.5T
Merck & Co., Inc.

Merck & Co., Inc.

MRKNYSEHealthcare● Active
$120.79
+$0.53(+0.44%)
Market Cap$298.3B
P/E Ratio—
52W High$125.14
52W Low$76.66
Overview

Merck & Co., Inc. (MRK) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

MRK · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$14.56B▲ +6.4% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$14.56B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+6.4%
vs prior fiscal year
Latest Quarter
$5.70B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$14.56BCash on Hand
Total Debt$50.53BTotal Debt
Net Cash / Net Debt−$35.97BNet Debt Position
Cash vs Debt Ratio
Cash 22%Debt 78%

Merck & Co., Inc. carries a net debt position of $35.97B. Total debt ($50.53B) exceeds cash on hand ($14.56B). Merck & Co., Inc. cash vs debt ratio: 22% cash / 78% debt.

Net Cash = Cash & ST Investments − Total Debt$14.56B − $50.53B = −$35.97B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
MRK annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$14.56B+6.4%
Dec 31, 2024$13.69B+93.0%
Dec 31, 2023$7.09B-46.2%
Dec 31, 2022$13.19B+62.9%
Dec 31, 2021$8.10B+0.6%
MRK cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Merck & Co., Inc.
Merck & Co., Inc.YOU
MRK
$14.56B4.9%
#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Merck & Co., Inc. (MRK) cash on hand as of December 31, 2025 is $14.56B, comprising $14.56B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Merck & Co., Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Merck & Co., Inc. cash reserves or cash position.

Merck & Co., Inc. annual cash on hand history shows increased +6.4% in 2025: increased +6.4% in 2025. Merck & Co., Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Merck & Co., Inc. carries total debt of $50.53B against cash of $14.56B, resulting in a net debt position of -$35.97B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

MRK cash on hand · 5 questions

As of December 31, 2025, Merck & Co., Inc. (MRK) has $14.56B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $14.56B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $5.70B. Data sourced from the annual 10-K filing via FMP.

MRK cash on handMRK cash reservesMRK cash 2025how much cash does MRK have

▸ Source: FMP /balance-sheet-statement · US GAAP · Merck & Co., Inc. · Merck & Co., Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025